Why Axsome Therapeutics Stock Jumped Over 20% in April
Axsome Therapeutics (AXSM 0.59%) has been growing sales rapidly with its Auvelity antidepressant. The biopharmaceutical company focuses on developing therapies for central nervous system (CNS) disorders.
Auvelity, launched in late 2022, has been approved to treat major depressive disorder (MDD) in adults, and sales have been growing quickly.
» Read more about: Why Axsome Therapeutics Stock Jumped Over 20% in April »
Read MoreThe Burst
Alert: 38% Upside In Super Boring Stock
Investment Alert: Buy Oracle (ORCL) Under $120
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Larry Ellison ranks among the richest men in the world thanks to the roaring success of the company he founded in 1977,
» Read more about: Alert: 38% Upside In Super Boring Stock »
Read MoreThe Ivy
Billionaire Builds Big Stake In Under-the-Radar ETF
George Soros had an old rule: invest first, investigate later. When a great opportunity seemed ripe for the picking, he would buy it, and figure out later if he was right.
It’s actually the opposite of what most funds do, which is to spend many months researching and dotting all their “i”s and crossing all their “t”s before patiently waiting for the price to get to the level they think is right.
» Read more about: Billionaire Builds Big Stake In Under-the-Radar ETF »
Read More